Fortive Work in process increased by 13.0% to $13.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 87.2%, from $108.80M to $13.90M. Over 5 years (FY 2020 to FY 2025), Work in process shows a downward trend with a -30.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $80.20M | $87.90M | $94.00M | $103.00M | $104.00M | $105.10M | $96.40M | $103.60M | $105.20M | $110.70M | $108.90M | $113.90M | $116.10M | $111.80M | $15.30M | $108.80M | $117.00M | $12.20M | $12.30M | $13.90M |
| QoQ Change | — | +9.6% | +6.9% | +9.6% | +1.0% | +1.1% | -8.3% | +7.5% | +1.5% | +5.2% | -1.6% | +4.6% | +1.9% | -3.7% | -86.3% | +611.1% | +7.5% | -89.6% | +0.8% | +13.0% |
| YoY Change | — | — | — | — | +29.7% | +19.6% | +2.6% | +0.6% | +1.2% | +5.3% | +13.0% | +9.9% | +10.4% | +1.0% | -86.0% | -4.5% | +0.8% | -89.1% | -19.6% | -87.2% |
| % of Inventories | 16.4% | 17.3% | 18.3% | 18.6% | 19.0% | 18.8% | 18.0% | 18.2% | 18.7% | 20.0% | 20.3% | 19.6% | 20.3% | 19.8% | 5.7% | 19.2% | 19.2% | 3.9% | 4.2% | 4.5% |
| Share Change | — | +0.9pp | +1.0pp | +0.3pp | +0.4pp | -0.2pp | -0.8pp | +0.2pp | +0.6pp | +1.3pp | +0.2pp | -0.7pp | +0.7pp | -0.5pp | -14.2pp | +13.5pp | +0.0pp | -15.2pp | +0.3pp | +0.3pp |